Jasper Therapeutics Successfully Completes Public Offering of Common Stock with Full Exercise of Underwriters’ Option
Jasper Therapeutics Successfully Completes Public Offering of Common Stock with Full Exercise of Underwriters’ Option REDWOOD CITY, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) Jasper Therapeutics, a biotechnology company based in California, has recently made headlines with the successful completion of their public offering of common stock. This achievement marks…